Bashar Hamad
Impact in
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
-
- Pharmaceutical Economics and Policy 3
-
- Inflammatory mediators and NSAID effects 2
- Cholinesterase and Neurodegenerative Diseases 1
- Co-authors
- Xiaoxiao Qian (1 shared paper)Peter Kirkpatrick (2 shared papers)Kurt Huber (2 shared papers)Uma Yasothan (2 shared papers)Basharut A. Syed (2 shared papers)Rami A. Al‐Horani (2 shared papers)Jalal K. Ghali (1 shared paper)Peter J. Kirkpatrick (1 shared paper)
- Partner nations
- United KingdomUnited StatesAustria
In The Last Decade
Bashar Hamad
14 papers receiving 448 citations
Peers
Comparison fields: 5 of 97
- Molecular Medicine 68
- Applied Microbiology and Biotechnology 14
- Pharmacology 89
- Pollution 53
- Internal Medicine 13
Countries citing papers authored by Bashar Hamad
This map shows the geographic impact of Bashar Hamad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bashar Hamad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bashar Hamad more than expected).
Fields of papers citing papers by Bashar Hamad
This network shows the impact of papers produced by Bashar Hamad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bashar Hamad. The network helps show where Bashar Hamad may publish in the future.
Co-authors
The 11 scholars most cited alongside Bashar Hamad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 219 | |
| 2 | 2015 | 43 | |
| 3 | 2009 | 27 | |
| 4 | 2014 | 26 | |
| 5 | 2011 | 24 | |
| 6 | 2019 | 23 | |
| 7 | 2021 | 22 | |
| 8 | 2016 | 19 | |
| 9 | 2009 | 16 | |
| 10 | 2017 | 15 | |
| 11 | 2018 | 12 | |
| 12 | 2014 | 5 | |
| 13 | 2024 | 5 | |
| 14 | 2015 | 4 | |
| 15 | 2025 | 0 |
About Bashar Hamad
Bashar Hamad is a scholar working on Economics and Econometrics, Pharmacology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Internal Medicine, having authored 15 papers that have together received 460 indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (3 papers), Pharmaceutical Economics and Policy (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (2 papers), Antibiotic Use and Resistance (2 papers), Inflammatory mediators and NSAID effects (2 papers), Pharmaceutical Practices and Patient Outcomes (1 paper), Cholinesterase and Neurodegenerative Diseases (1 paper) and Cystic Fibrosis Research Advances (1 paper). The work is most often cited by research in Molecular Medicine (68 citations), Applied Microbiology and Biotechnology (14 citations), Pharmacology (89 citations), Pollution (53 citations) and Internal Medicine (13 citations). Bashar Hamad has collaborated with scholars based in United Kingdom, United States and Austria. Frequent co-authors include Xiaoxiao Qian, Peter Kirkpatrick, Kurt Huber, Uma Yasothan, Basharut A. Syed, Rami A. Al‐Horani, Jalal K. Ghali, Peter J. Kirkpatrick, Ian Sander and Nuno Damácio de Carvalho Félix. Their work appears in journals such as Nature Reviews Drug Discovery and Hospital Pharmacy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.